Others

CIPLA LTD. - USFDA Cgmp Inspection Completed At CiplaS API Manufacturing Facility In Virgonagar, Bengaluru

| Updated on July 20, 2019 Published on July 20, 2019

We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection at our API manufacturing facility in Virgonangar, Bengaluru, from 15th June, 2019 to 19th June, 2019

The inspection ended with 7 observations, none of which were repeat or related to data integrity. The Company will respond to the agency within the stipulated timeline.


Kindly take the above information on record.

Pdf Link: CIPLA LTD. - USFDA Cgmp Inspection Completed At CiplaS API Manufacturing Facility In Virgonagar, Bengaluru

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 20, 2019
This article is closed for comments.
Please Email the Editor